Spine Biologics Market Report 2024 – Spine Biologics Market Size, Share And Trends | Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation

The spine biologics market size is expected to see strong growth in the next few years. It will grow to $2.91 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%.  The growth in the forecast period can be attributed to technological innovations, increasing adoption of regenerative medicine, rising investment in R&D, growing prevalence of obesity and sedentary lifestyles, expanding healthcare access in emerging markets, favorable regulatory approvals, and increasing collaborations and partnerships within the industry. Major trends in the forecast period include emergence of novel regenerative therapies, integration of artificial intelligence in treatment planning, expansion of personalized medicine approaches, adoption of 3D printing for customized implants, and development of bioengineered scaffolds for enhanced tissue regeneration.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/spine-biologics-global-market-report

Scope Of Spine Biologics Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Spine Biologics Market Overview

Market Drivers –
The rising number of road accidents is expected to propel the growth of the spinal biologics market going forward. A road accident refers to an unintended and unforeseen event involving one or more vehicles on a public road that often results in severe spinal injuries, necessitating advanced medical interventions for effective treatment and recovery. Road accidents are on the rise globally due to a variety of factors, such as distracted driving, an increase in traffic volume, poor road conditions and infrastructure, and alcohol and drug impairment. Spine biologics serve an essential role in improving patient outcomes by boosting spinal fusion, speeding healing, lowering surgical risks, enhancing pain management, and decreasing the need for revision operations. For instance, in May 2022, according to the National Highway Traffic Safety Administration, a US-based government agency, an estimated 42,915 people died in motor vehicle traffic crashes last year in the US, marking a 10.5% rise from the 38,824 fatalities in 2020. Therefore, the rising number of road accidents is driving the growth of the spinal biologics market.

Market Trends –
Major companies operating in the spinal biologics market are developing advanced products, such as synthetic bioactive bone grafts, to better serve patients and gain a competitive edge in the market. Synthetic bioactive bone graft refers to a man-made spine biologic engineered to support and enhance bone growth and healing in spinal fusion surgeries. For instance, in February 2022, Orthofix Medical Inc., a US-based spine and orthopedics company, launched Opus BA, a synthetic bioactive bone graft for cervical and lumbar spine fusion procedures. It is offered in putty and strip forms and acts as a scaffold for bone growth, which is reabsorbed and replaced by natural bone. It can be hydrated with autogenous bone marrow or autografted with saline. Opus BA features an osteoconductive matrix made from carbonate apatite bone mineral, bioactive glass, and Type 1 collagen, stimulating bone growth and resorption.

The spine biologics market covered in this report is segmented –
1) By Product: Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy
2) By Surgery Type: Anterior Cervical Discectomy And Fusion (ACDF), ??Posterior Lumbar Interbody Fusion (PLIF), Transforaminal Lumbar Interbody Fusion (TLIF), ??Anterior Lumbar Interbody Fusion (ALIF), ??Lateral Lumbar Interbody Fusion (LLIF), Other Surgery Types
3) By Application: Spinal Fusion, Spinal Non-Union And Fracture Repair, Degenerative Disc Disease Treatment, Other Applications
4) By End User: Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Other End Users

Get an inside scoop of the spine biologics market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15928&type=smp

Regional Insights –
North America was the largest region in the spine biologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spine biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies –
Major companies operating in the spine biologics market are Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Baxter International Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Arthrex Inc., Integra LifeSciences Corporation, Bone Biologics Corp., InVivo Therapeutics Corp., RTI Surgical Inc., Paragon 28 Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., CoreLink LLC  , Spinal Elements Inc., Life Spine Inc., Innovasis Inc., Camber Spine Technologies LLC, SurGenTec LLC, ChoiceSpine LLC, Cerapedics Inc, Aziyo Biologics, Amedica Corporation

Table of Contents
1. Executive Summary
2. Spine Biologics Market Report Structure
3. Spine Biologics Market Trends And Strategies
4. Spine Biologics Market – Macro Economic Scenario
5. Spine Biologics Market Size And Growth
…..
27. Spine Biologics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Read Related Topics:
https://goodprnews.com/influenza-treatment-market-size/
https://goodprnews.com/lipid-regulators-market-size/
https://goodprnews.com/multi-cancer-early-detection-market-size/
https://topprnews.com/influenza-treatment-market-share/
https://topprnews.com/lipid-regulators-market-share/
https://topprnews.com/multi-cancer-early-detection-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model